DGCR2, standing for DiGeorge syndrome critical region gene 2, is a protein that is encoded by the DGCR2 gene located on chromosome 22. This gene is situated within a segment known as the DiGeorge syndrome chromosomal region, which is implicated in the 22q11.2 deletion syndrome. The protein is also referred to as LANCL1, highlighting its homology to the lanthionine synthetase C-like protein family. DGCR2 is a transmembrane protein, which suggests that it has a role in signal transduction across the cellular membrane. While the precise function of DGCR2 is not fully understood, it is believed to be involved in neural crest development and to play a role in the cardiovascular and craniofacial development.
DiGeorge syndrome, also known as 22q11.2 deletion syndrome, is a congenital condition that results in a spectrum of manifestations, including cardiac anomalies, characteristic facial features, immune deficiencies, and cognitive and behavioral issues. The deletion of a small segment of chromosome 22, which includes the DGCR2 gene among others, is thought to disrupt the normal development of several body systems.The study of DGCR2 is significant because understanding its function and the pathways it is involved in can contribute to a better comprehension of the molecular basis of DiGeorge syndrome. Such knowledge can lead to improved diagnostic, prognostic, and strategies for individuals affected by this and related syndromes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid, a metabolite of Vitamin A, is crucial in neural development and may indirectly influence DGCR2 activity through its role in gene expression regulation in neural tissues. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium is used in neurological contexts and can impact signaling pathways relevant to neural development, potentially influencing DGCR2 function. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid, used in neurology, has epigenetic effects and can influence gene expression, potentially affecting DGCR2 activity. | ||||||
Fluoxetine | 54910-89-3 | sc-279166 | 500 mg | $318.00 | 9 | |
Fluoxetine, an SSRI, can affect neuroplasticity and indirectly influence genes involved in neural development, possibly including DGCR2. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone, a PPAR-gamma agonist, has been shown to influence neurogenesis and may indirectly affect DGCR2 activity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has multiple biological activities, including effects on neural cells, potentially influencing DGCR2-related pathways. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Vitamin D3 is implicated in brain development and function and could indirectly influence DGCR2 activity through its role in neural development. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Nicotinamide, a form of Vitamin B3, is involved in cellular metabolism and has roles in neuroprotection, possibly influencing DGCR2. | ||||||
Folic Acid | 59-30-3 | sc-204758 | 10 g | $73.00 | 2 | |
Folic Acid is essential for neural development and could indirectly influence DGCR2 function through its role in neurogenesis and development. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, found in green tea, has neuroprotective properties and may influence neural development pathways relevant to DGCR2. | ||||||